| Drug Name: | Sitagliptin |
|---|
| Drug Class: | Dipeptidyl peptidase-4 (DPP-4) inhibitor |
|---|
| Mechanism of Action: | - Inhibits the enzyme DPP-4, which breaks down incretin hormones
- Increases insulin secretion and decreases glucagon secretion
|
|---|
| Use: | |
|---|
| Side Effects: | - Upper respiratory tract infection
- Headache
- Hypoglycemia
- Pancreatitis
|
|---|
| Contraindications: | - Type 1 diabetes mellitus
- Diabetic ketoacidosis
- History of pancreatitis
|
|---|
| Specialty: | - Endocrinology
- Internal Medicine
|
|---|